In the present study target-oriented nanoparticlesbased on biodegradable human serum albumin (HAS)loaded with the cytostatic drug doxorubicin were tested.Trastuzumab was covalently linked onto the surface of thenanoparticles. HER2 overexpressing breast cancer cellsshowed a good cellular binding and uptake of thesenanoparticles. The specific transport of the cytostatic drugdoxorubicin with the nanoparticle formulation into theHER2 overexpressing breast cancer cells, their releaseand biological activity was demonstrated.
展开▼